Polli EE - Search Results

1

Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia.

Lambertenghi-Deliliers G, Maiolo AT, Annaloro C, Cortelezzi A, Pogliani E, Ganzina F, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: polli ee. Eur J Cancer Clin Oncol. 1987 Jul;23(7):1041-5. doi: 10.1016/0277-5379(87)90356-7. Eur J Cancer Clin Oncol. 1987. PMID: 3478198

2

Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosine.

Lambertenghi-Deliliers G, Maiolo AT, Annaloro C, Pogliani E, Baldini L, Polli E. Lambertenghi-Deliliers G, et al. Cancer. 1984 Jul 15;54(2):199-201. doi: 10.1002/1097-0142(19840715)54:2<199::aid-cncr2820540203>3.0.co;2-v. Cancer. 1984. PMID: 6586276

3

Idarubicin in blastic crisis of chronic myelogenous leukemia.

Lambertenghi-Deliliers G, Annaloro C, Cortellaro M, Pozzoli E, Oriani A, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: polli ee. Haematologica. 1991 Sep-Oct;76(5):406-8. Haematologica. 1991. PMID: 1806446 Clinical Trial.

4

Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.

Lambertenghi-Deliliers G, Annaloro C, Cortelezzi A, Cortellaro M, Della Volpe A, Maiolo AT, Mozzana R, Pogliani E, Pozzoli E, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: polli ee. Semin Oncol. 1989 Feb;16(1 Suppl 2):16-20. Semin Oncol. 1989. PMID: 2928806 No abstract available.

5

Oral idarubicin in adult acute leukemia: a preliminary experience.

Lambertenghi-Deliliers G, Pogliani E, Annaloro C, Pacciarini MA, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: polli ee. Tumori. 1986 Apr 30;72(2):157-61. doi: 10.1177/030089168607200207. Tumori. 1986. PMID: 3458337

6

1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosis.

Foa P, Maiolo AT, Cortellaro M, Ortolani S, Pogliani E, Deliliers GL, Iurlo A, Zocchi L, Gualdoni A, Polli E. Foa P, et al. Haematologica. 1990 May-Jun;75(3):294-5. Haematologica. 1990. PMID: 2227630

7

Therapy with interferons in blood diseases.

Polli E, Cortelezzi A. Polli E, et al. Acta Haematol. 1987;78 Suppl 1:64-9. doi: 10.1159/000205905. Acta Haematol. 1987. PMID: 2449025 Review.

8

Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.

Ludwig H, Cortelezzi A, Scheithauer W, Van Camp BG, Kuzmits R, Fillet G, Peetermans M, Polli E, Flener R. Ludwig H, et al. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1111-6. doi: 10.1016/0277-5379(86)90015-5. Eur J Cancer Clin Oncol. 1986. PMID: 3536528 Free article. Clinical Trial.

9

Chronic myelogenous leukemia: state of the art.

Polli EE, Pozzoli E, Annaloro C. Polli EE, et al. Ann Ital Med Int. 1991 Oct-Dec;6(4 Pt 2):491-7. Ann Ital Med Int. 1991. PMID: 1840816 Review.

10

Immunoreactive calcitonin: a tumor marker for myelogenous leukemias.

Foa P, Ortolani S, Pogliani EM, Iurlo A, Gualdoni A, Maiolo AT, Polli EE. Foa P, et al. Among authors: polli ee. Int J Biol Markers. 1990 Jan-Mar;5(1):27-30. doi: 10.1177/172460089000500105. Int J Biol Markers. 1990. PMID: 2230349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters